Harvard Bioscience Gross Profit 2010-2024 | HBIO

Harvard Bioscience gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Harvard Bioscience Annual Gross Profit
(Millions of US $)
2024 $55
2023 $66
2022 $61
2021 $68
2020 $58
2019 $64
2018 $63
2017 $39
2016 $48
2015 $49
2014 $49
2013 $48
2012 $52
2011 $50
2010 $52
2009 $42
Harvard Bioscience Quarterly Gross Profit
(Millions of US $)
2024-12-31 $14
2024-09-30 $13
2024-06-30 $13
2024-03-31 $15
2023-12-31 $16
2023-09-30 $15
2023-06-30 $17
2023-03-31 $18
2022-12-31 $16
2022-09-30 $12
2022-06-30 $17
2022-03-31 $16
2021-12-31 $20
2021-09-30 $16
2021-06-30 $16
2021-03-31 $15
2020-12-31 $18
2020-09-30 $13
2020-06-30 $14
2020-03-31 $13
2019-12-31 $17
2019-09-30 $15
2019-06-30 $16
2019-03-31 $16
2018-12-31 $19
2018-09-30 $16
2018-06-30 $15
2018-03-31 $13
2017-12-31 $11
2017-09-30 $10
2017-06-30 $9
2017-03-31 $10
2016-12-31 $12
2016-09-30 $12
2016-06-30 $12
2016-03-31 $13
2015-12-31 $13
2015-09-30 $12
2015-06-30 $13
2015-03-31 $11
2014-12-31 $14
2014-09-30 $11
2014-06-30 $12
2014-03-31 $12
2013-12-31 $12
2013-09-30 $11
2013-06-30 $12
2013-03-31 $12
2012-12-31 $13
2012-09-30 $12
2012-06-30 $14
2012-03-31 $13
2011-12-31 $13
2011-09-30 $12
2011-06-30 $13
2011-03-31 $12
2010-12-31 $14
2010-09-30 $13
2010-06-30 $12
2010-03-31 $13
2009-12-31 $13
2009-09-30 $10
2009-06-30 $9
2009-03-31 $9
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.015B $0.094B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $5.687B 15.97
Kewaunee Scientific (KEQU) United States $0.107B 7.49